Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Puzanov

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Expert Opinion on Orphan Drugs|September 7, 2016
Pembrolizumab for the treatment of advanced melanomaMichael C Burns, Aidan O'Donnell, Igor Puzanov
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancerJeffrey A Sosman, Igor Puzanov, Michael B Atkins
Oncotargets and Therapy|June 5, 2020
Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on PembrolizumabAbhay Singh, Inderpreet Singh, Namrata Singh, et al.
Melanoma Research|December 5, 2023
Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunityBenjamin Switzer, Igor Puzanov, Shipra Gandhi, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2023
Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasmaMelody F Myszkiewicz, Igor Puzanov, Andrew K L Goey
Journal for Immunotherapy of Cancer|July 17, 2021
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitorsBenjamin Switzer, John Haanen, Paul C Lorigan, et al.
Gastroenterology Research|February 1, 2014
Infectious Colitis Associated With Ipilimumab TherapyJessica L McCutcheon, Colt M McClain, Igor Puzanov, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 4, 2023
Evolving Management of Stage IV MelanomaBenjamin Switzer, Sophie Piperno-Neumann, James Lyon, et al.
Journal of Pain and Symptom Management|May 25, 2018
Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care ClinicianEric D Hansen, Xiao Wang, Amy A Case, et al.
JCO Oncology Practice|February 8, 2022
Managing Metastatic Melanoma in 2022: A Clinical ReviewBenjamin Switzer, Igor Puzanov, Joseph J Skitzki, et al.
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Expert Opinion on Orphan Drugs|September 7, 2016
Pembrolizumab for the treatment of advanced melanomaMichael C Burns, Aidan O'Donnell, Igor Puzanov
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancerJeffrey A Sosman, Igor Puzanov, Michael B Atkins
Oncotargets and Therapy|June 5, 2020
Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on PembrolizumabAbhay Singh, Inderpreet Singh, Namrata Singh, et al.
Melanoma Research|December 5, 2023
Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunityBenjamin Switzer, Igor Puzanov, Shipra Gandhi, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 21, 2023
Development and validation of an LC-MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasmaMelody F Myszkiewicz, Igor Puzanov, Andrew K L Goey
Journal for Immunotherapy of Cancer|July 17, 2021
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitorsBenjamin Switzer, John Haanen, Paul C Lorigan, et al.
Gastroenterology Research|February 1, 2014
Infectious Colitis Associated With Ipilimumab TherapyJessica L McCutcheon, Colt M McClain, Igor Puzanov, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 4, 2023
Evolving Management of Stage IV MelanomaBenjamin Switzer, Sophie Piperno-Neumann, James Lyon, et al.
Journal of Pain and Symptom Management|May 25, 2018
Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care ClinicianEric D Hansen, Xiao Wang, Amy A Case, et al.
JCO Oncology Practice|February 8, 2022
Managing Metastatic Melanoma in 2022: A Clinical ReviewBenjamin Switzer, Igor Puzanov, Joseph J Skitzki, et al.
Pageof 21